首页> 外文期刊>Diabetes >Prolonged Survival of Rat Islet and Skin Xenografts in Mice Treated with Donor Splenocytes and Anti- CD154 Monoclonal Antibody
【24h】

Prolonged Survival of Rat Islet and Skin Xenografts in Mice Treated with Donor Splenocytes and Anti- CD154 Monoclonal Antibody

机译:供体脾细胞和抗CD154单克隆抗体治疗的大鼠胰岛和皮肤异种移植物的存活时间延长

获取原文
获取原文并翻译 | 示例
           

摘要

Treatmet of C57BL/6 mice with one transfusion of BALB/c spleen cells and a brief course of anti-CD154 (anti-CD40 ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for ~50 days without further intervention. We now report adaptation of this protocol tot he trans- plantation of islet and skin xenografts. We observed prolonged survival of rat islet xenografts in mice treated with donor-specific spleen cell transfusion and anti-CD154 monoclonal antibody (mAb).
机译:一次输注BALB / c脾细胞和一小段抗CD154(抗CD40配体)抗体的C57BL / 6小鼠处理平台可使BALB / c胰岛移植物无限期存活,而BALB / c皮肤移植物可存活约50岁无需进一步干预的日子。现在,我们报道了该协议对胰岛和皮肤异种移植的适应性。我们观察到用供体特异性脾细胞输注和抗CD154单克隆抗体(mAb)处理的小鼠中大鼠胰岛异种移植物的存活时间延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号